Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
Chimeric antigen receptor (CAR) T cells represent one of the newest frontiers of cell therapy. Their application currently involves relapsed/refractory aggressive B cell lymphoma and leukemia as a standard of care, while several studies are exploring CAR-T to treat multiple myeloma and other hematol...
Saved in:
| Main Authors: | Eugenio Galli, Silvia Bellesi, Marcello Viscovo, Federica Sorà, Stefan Hohaus, Nicola Piccirillo, Luca Laurenti, Patrizia Chiusolo, Valerio De Stefano, Simona Sica, Gina Zini |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2021-10-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | http://mjhid.org/index.php/mjhid/article/view/4745 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correlation of cytomorphology with flowcytometric immunophenotyping in patients of acute leukemia in tertiary care hospital
by: Garima Pandey, et al.
Published: (2022-03-01) -
The use of T-cells with chimeric antigen receptor (CAR-T) in combination with chemotherapy and radiotherapy for the treatment of solid tumors
by: M. R. Khaliulin, et al.
Published: (2024-04-01) -
Risk Prediction of Bladder Carcinomas in Atypical Urine Specimens by Redefining Diagnostic Cytomorphological Criteria
by: Prakriti Shukla, et al.
Published: (2025-01-01) -
NKG2D/CD28 chimeric receptor boosts cytotoxicity and durability of CAR-T cells for solid and hematological tumors
by: Xia Teng, et al.
Published: (2025-04-01) -
Expanding the Horizons of CAR-T Cell Therapy: A Review of Therapeutic Targets Across Diverse Diseases
by: Alejandrina Hernández-López, et al.
Published: (2025-01-01)